Vitamin A supplements and mortality related to measles: A randomised clinical trial

Andrew J.G. Barclay, Allen Foster, Alfred Sommer

Research output: Contribution to journalArticlepeer-review

Abstract

One hundred and eighty children admitted with measles were randomly allocated to receive routine treatment alone or with additional large doses of vitamin A (200 000 IU orally immediately and again the next day). Baseline characteristics of the two groups were virtually identical for, age, severity of measles, and vitamin A and general nutritional states. In 91% of the children serum vitamin A concentrations were less than 0·56 μmol/1. Of the 88 subjects given vitamin A supplements, six (7%) died; of the 92 controls, 12 (13%) died (p=0·13). This difference in mortality was most obvious for children aged under 2 years (one death out of 46 children receiving supplements versus seven deaths out of 42 controls; p<0·05) and for cases complicated by croup or laryngotracheobronchitis. Mortality was several times higher in marasmic than in better nourished children, regardless of study allocation (p<0·01).

Original languageEnglish (US)
Pages (from-to)294-296
Number of pages3
JournalBritish medical journal (Clinical research ed.)
Volume294
Issue number6567
DOIs
StatePublished - 1987

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Vitamin A supplements and mortality related to measles: A randomised clinical trial'. Together they form a unique fingerprint.

Cite this